Pharma

(L to R) Andrew Hopper, Carson Pickens, Gilad Jacobs, Stacie Ruth, Grace Cordavano, and Kelly McKee discuss Patient Co-Creation last month at the Connected Health Conference in Boston. Photo by Jonah Comstock.

By  Jonah Comstock 01:47 pm November 27, 2019
Healthcare stakeholders — from providers to payers to pharma and medical device companies — are more and more starting to include patients in the design process for new innovations and initiatives. But while that co-design is a good first step, it’s not enough, experts at the Connected Health Conference in Boston last month argued. “Every health innovator wants to maximize their market success,”...
By  Dave Muoio 03:12 pm November 21, 2019
Welldoc is tapping Astellas Pharma to assist Japanese and Asian commercialization efforts for the former’s digital therapeutic for patients with diabetes, the companies announced yesterday. To kick off the deal, Astellas is making an upfront $15 million payment to Welldoc, which will allow the pharma to jointly develop and commercialize the BlueStar product in the region. The two will also be...
By  Laura Lovett 01:51 pm November 20, 2019
Yesterday Propeller Health, maker of digital management tools for patients with respiratory conditions, announced a new deal with CVS, Walmart, Kroger, and Rite Aid, allowing its members to tap into the retail giants’ pharmacy services through the Propeller app.  Propeller is best known for its sensor-enabled inhalers, which can give patients and providers insights about use, symptom triggers and...
By  Laura Lovett 12:23 pm November 19, 2019
This morning Deloitte launched ConvergeHEALTH Connect, a new suite of four new healthcare products targeting a range of concentrations from public health care to personalized care, all of which runs on the Salesforce Health Cloud.  The full list includes tools for patient engagement, public health programs, providers and payers. The first tool specifically aims to help life science companies...

Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.

By  Dave Muoio 01:23 pm November 18, 2019
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia. These comments were accompanied by the official kickoff of CHIEF-HF,...
By  Laura Lovett 11:49 am November 18, 2019
This morning Biofourmis, maker of an artificial intelligence-enabled monitoring and decision support platform, announced its plans to acquire Zürich, Switzerland-based wearable biosensor company Biovotion. The terms of the deal are not disclosed; however, we do know the deal is made up of a combination of cash and equity.  The acquisition will include Biovotion’s clinical grade-wearable...
By  Tammy Lovell 05:57 am November 13, 2019
Health tech manufacturer Phillips-Medisize has announced the opening of a global innovation and development centre in Copenhagen, Denmark to support its long-term growth plans for advanced injection, wearable devices and connected technologies. The Molex company says it plans for the centre, based in the Teknikerbyen area, to help accelerate the creation of differentiated drug delivery devices...
Woman with laptop
By  Mike Miliard 06:07 am November 5, 2019
Kyruus' new Patient Access Journey Report, which polled patients about their healthcare preferences, finds an appetite for a streamlined, digitally mature scheduling experience.
patient with tablet
By  Jeff Lagasse 06:07 am November 5, 2019
A robust web presence and offerings like online scheduling and telehealth are imperatives for health systems looking to stay relevant.
By  Dave Muoio 11:47 am October 30, 2019
Pear Therapeutics has announced a new deal with Ironwood Pharmaceuticals that will explore the platform’s potential for patients with certain gastrointestinal (GI) conditions. “We are excited to be partnering with Ironwood on this initiative and believe there is a compelling clinical rationale for use of [prescription digital therapeutics] in treating GI diseases,” Dr. Corey McCann, president and...